INNOVATE BIOPHARMACEUTICLS I's ticker is and the CUSIP is 45782F905. A total of 3 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $18,000 | – | 370 | +12233.3% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 3 | -78.6% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 14 | -33.3% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 21 | -30.0% | 0.00% | – |
| Q1 2019 | $5,000 | -78.3% | 30 | -70.9% | 0.00% | – |
| Q4 2018 | $23,000 | -82.7% | 103 | -47.4% | 0.00% | – |
| Q3 2018 | $133,000 | -14.2% | 196 | +197.0% | 0.00% | -100.0% |
| Q2 2018 | $155,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,300 | $14,000 | 0.00% |
| SIMPLEX TRADING, LLC | 21 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |